vimarsana.com
Home
Live Updates
New Nature Paper Relies on LUMICKS' C-Trap Technology to Und
New Nature Paper Relies on LUMICKS' C-Trap Technology to Und
New Nature Paper Relies on LUMICKS' C-Trap Technology to Understand Functionality of Key Protein Involved with Incorrect DNA Repair of Dangerous Lesions Linked to Cancer Predisposition
AMSTERDAM, Feb. 15, 2022 /PRNewswire/ -- LUMICKS, a leading life science tools company that develops equipment for dynamic single-molecule and cell avidity analysis, today announced that its
Related Keywords
New York ,
United States ,
Bluelake ,
London ,
City Of ,
United Kingdom ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Simonj Boulton ,
Sloan Kettering ,
Andrea Candelli ,
Kassandra Barbetsea ,
Simon Powell ,
David Rueda ,
Imperial College London ,
London Institute Of Medical Sciences ,
Francis Crick Institute ,
Memorial Sloan Kettering ,
Weill Cornell Medical ,
London Institute ,
Scientific Officer ,
Dynamic Single Molecule ,
Cell Avidity ,
Label Free Microscopy ,
Avidity Analyzer ,
Nature ,
Paper ,
Relies ,
Lumicks ,
Trap ,
Technology ,
Nderstand ,
Functionality ,
Protein ,
Involved ,
Incorrect ,
Repair ,
Dangerous ,
Sesions ,
Inked ,
Dancer ,
Predisposition ,